Group One Trading’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5K Buy
+10,000
New +$31.1K ﹤0.01% 5739
2025
Q4
Sell
-7,500
Closed -$21.7K 7997
2025
Q3
$21.7K Sell
7,500
-9,900
-57% -$22.4K ﹤0.01% 6641
2025
Q2
$35.3K Buy
+17,400
New +$30.3K ﹤0.01% 5848
2025
Q1
Sell
-2,500
Closed -$6.75K 7487
2024
Q4
$6.75K Sell
2,500
-46,900
-95% -$147K ﹤0.01% 6295
2024
Q3
$187K Buy
49,400
+32,900
+199% +$115K ﹤0.01% 3681
2024
Q2
$65.8K Buy
16,500
+13,100
+385% +$43.3K ﹤0.01% 4298
2024
Q1
$10.1K Buy
3,400
+2,600
+325% +$9.32K ﹤0.01% 5861
2023
Q4
$4K Sell
800
-4,200
-84% -$13.5K ﹤0.01% 6592
2023
Q3
$14.3K Sell
5,000
-15,000
-75% -$45.7K ﹤0.01% 6133
2023
Q2
$59.1K Buy
+20,000
New +$43.7K ﹤0.01% 5130
2023
Q1
Sell
-3,800
Closed -$7.75K 7114
2022
Q4
$7.75K Sell
3,800
-2,000
-34% -$5.16K ﹤0.01% 6137
2022
Q3
$18K Buy
5,800
+2,000
+53% +$6.3K ﹤0.01% 6118
2022
Q2
$14K Buy
+3,800
New +$13K ﹤0.01% 6542
2021
Q4
Sell
-100
Closed -$1K 8107
2021
Q3
$1K Hold
100
﹤0.01% 7995
2021
Q2
$1K Sell
100
-600
-86% -$4.15K ﹤0.01% 7994
2021
Q1
$5K Buy
+700
New +$5K ﹤0.01% 7223

Other funds holding ACIU

Group One Trading's ACIU Position: Q4 2024 in Review

Group One Trading sold out of AC Immune (ACIU) in Q4 2024, closing a stake of 24,074 shares — an estimated $75.2K sold.

Group One Trading first reported a position in ACIU in Q2 2021 and held it in 6 quarters. The position peaked at $91K in Q3 2024. 45 funds tracked by Wall St. Rank hold ACIU as of Q4 2024.

  • Group One Trading reported no remaining AC Immune position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 24,074 AC Immune shares in Q4 2024, an estimated $75.2K.
  • Group One Trading first reported a position in AC Immune in Q2 2021 and held it in 6 quarters.
  • Group One Trading's AC Immune position peaked at $91K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held AC Immune as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.